Suppr超能文献

与 Hb H 病相关的α-珠蛋白基因型:来自阿曼的报告及东地中海地区文献复习。

α-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region.

机构信息

Department of Hematology, Sultan Qaboos University Hospital, Muscat, Oman.

Department of Hematology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.

出版信息

Hemoglobin. 2020 Jan;44(1):20-26. doi: 10.1080/03630269.2020.1720709. Epub 2020 Feb 5.

Abstract

α-Thalassemia (α-thal) is the most common autosomal recessive hemoglobinopathy. There is a vast diversity and geographical variability in underlying genotypes in Hb H (β4) patients. Herein, we describe the genotypes found in the largest report of Omani Hb H patients. Moreover, we reviewed and summarized the literature published from the Eastern Mediterranean region. A retrospective review of all genetically confirmed Hb H disease patients diagnosed between 2007 and 2017 at Sultan Qaboos University Hospital, Muscat, Oman, was performed. Hematological parameters and clinical presentations were assessed. Both α-globin genes were screened for deletional and nondeletional mutations using a stepwise diagnostic strategy as described before. A total of 52 patients (27 females and 25 males) with a mean age of 20.6 years (range 0.23-80.0) were molecularly confirmed to carry Hb H disease. The patients had a hemoglobin (Hb) level of 9.3 g/dL (range 5.7-13.0) and mean corpuscular volume (MCV) of 58.4 fL (range 48.2-82.1). A total of eight genotype combinations were identified, with α2 polyadenylation signal mutation (polyA1) (AATAA>AATAA (αα/αα), often cited as αα/αα, being the most common (53.8%) followed by -α/- - (28.8%). Our cohort also included patients with combinations of α with other Hb variants: αα/αα with Hb S (: c.20A>T) trait ( = 2), -α/αα ( = 2) and αα (: c.56delG)/αα ( = 1). Nondeletional Hb H disease due to the α mutation is the most common in Omanis. Molecular diagnosis is necessary for accurate confirmation of the diagnosis of α-thal, determination of underlying genotypes, follow-up and counseling.

摘要

α-地中海贫血(α-thal)是最常见的常染色体隐性血红蛋白病。在 Hb H(β4)患者的潜在基因型中,存在着广泛的多样性和地理变异性。在此,我们描述了在阿曼最大的 Hb H 患者报告中发现的基因型。此外,我们回顾并总结了来自东地中海地区发表的文献。对 2007 年至 2017 年在阿曼马斯喀特苏丹卡布斯大学医院诊断的所有经基因确认的 Hb H 疾病患者进行了回顾性分析。评估了血液学参数和临床表现。使用逐步诊断策略对两个α-珠蛋白基因进行缺失和非缺失突变的筛查,如前所述。共有 52 名患者(27 名女性和 25 名男性),平均年龄为 20.6 岁(范围为 0.23-80.0),经分子确认为携带 Hb H 疾病。患者的血红蛋白(Hb)水平为 9.3g/dL(范围为 5.7-13.0),平均红细胞体积(MCV)为 58.4fL(范围为 48.2-82.1)。共鉴定出 8 种基因型组合,其中α2 多聚腺苷酸化信号突变(polyA1)(AATAA>AATAA(αα/αα)最常见(53.8%),其次为-α/-(28.8%)。我们的队列还包括与其他血红蛋白变异体组合的患者:αα/αα与 Hb S(: c.20A>T)特征( = 2)、-α/αα( = 2)和 αα(: c.56delG)/αα( = 1)。由于α突变导致的非缺失性 Hb H 疾病在阿曼人中最为常见。分子诊断对于准确确认α-thal 诊断、确定潜在基因型、随访和咨询是必要的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验